At the intersection of personal health and wearable technology, two identically priced smart rings—the established Oura Ring 4 and the upstart Circular Ring 2—invite consumers to consider not just what a device measures, but what it costs to know oneself over time. The Oura carries a monthly subscription that compounds its sticker price, while Circular promises freedom from recurring fees, though that promise grows more conditional as its roadmap unfolds. In the end, the more seasoned device wins on depth and comfort, but the challenger raises questions about cardiac monitoring and battery end
Tom's Guide
· Sep 20, 2025
· technology
· 5 min read
High
Sourcing: Verified
Oura Ring 4 edges Circular Ring 2 in smart ring showdown despite lower cost
◉
General News
6393 related articles
Hochul Seeks Second Term, Arguing New York Has Recovered From Pandemic
The New York Times · 100% match
NYC Mayor Takes Low-Key Upstate Vacation, Delighting Local Spotters
The New York Times · 50% match
NYC 911 Outage Went Public-Silent as Officials Withheld Information
The New York Times · 50% match
Harry and Meghan's England Return: A Risky Homecoming
The New York Times · 50% match
Massive hailstorm forces Vuelta a España stage abandonment in Pyrenees
The Guardian · 50% match
Related Coverage
NPR · Aug 25
Indonesia's Wildfires Choke Cities as Residents Pray for Rain
Massive wildfires across central and western Indonesia have scorched forests and peatland, generating thick smoke that b…
Google News · Aug 25 Starbucks Brings Back Pumpkin Spice Latte With Six New Fall DrinksStarbucks launches its annual Pumpkin Spice Latte alongside six new fall drinks, marking the start of the seasonal bever…
The Guardian · Aug 25 Matcha boom doubles in Australia as $8 green lattes become café stapleMatcha orders in Australia have doubled year-on-year, with under-35s driving demand for the $8 green beverage now consid…
The Guardian · Aug 25 Europe's summer heatwaves claim at least 35,000 excess deaths, toll expected to riseAt least 35,000 excess deaths occurred across Europe during four record-breaking summer heatwaves, with the true toll li…
Bias & Framing
⚖
Article shows center-right tech product bias favoring established brand (Oura) despite acknowledging competitor's advantages; uses positive framing for winner despite lower cost alternative.
Bias Direction
center-right
Confidence
MED
Establishment preference framing: declares Oura the 'hands-down favorite' upfront, then structures comparison to justify predetermined conclusion. Uses 'jury is still out' qualifier for competitor while presenting Oura as proven.
hands-down favorite
revolutionary new digital sizing process
understandably frustrated
In Circular's defense
edges...despite lower cost
User testimonials from Circular Ring 2 owners
Long-term durability data comparison
Cost-benefit analysis from consumer perspective
Circular's response to subscription concerns
Independent third-party validation of health metrics
Perspective of Kickstarter backers on value proposition
Geopolitical Impact
🌎
Consumer tech product comparison has no geopolitical implications; article discusses smart ring features and pricing between two commercial devices.
Escalation Risk
low
Confidence
HIGH
Economic Lens
📈
Smart ring market intensifies with Oura Ring 4 and Circular Ring 2 competing on features and pricing, signaling growing consumer demand for wearable health technology and subscription-based health data monetization models.
Market Signal
bullish
Confidence
MED
Consumer Electronics/Wearables
Healthcare Technology
Digital Health/Telemedicine
Software/Subscription Services
Retail/E-commerce
Consumers benefit from increased competition driving innovation in health monitoring features (ECG, AFib detection, glucose monitoring) at similar price points ($349). However, emerging subscription models and paywalled premium features may increase long-term ownership costs, creating a tiered access ecosystem for health data.
Potential regulatory scrutiny on health data privacy, accuracy claims for medical-grade features (ECG, AFib detection), and transparency requirements for subscription models. FDA may need to clarify classification of consumer wearables making clinical claims. Consumer protection agencies may address misleading 'subscription-free' marketing when future features require payment.